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Abstract
Objective To evaluate the effects of dietary and lifestyle interventions
in pregnancy on maternal and fetal weight and to quantify the effects of
these interventions on obstetric outcomes.
Design Systematic review and meta-analysis.
Data sources Major databases from inception to January 2012 without
language restrictions.
Study selection Randomised controlled trials that evaluated any dietary
or lifestyle interventions with potential to influence maternal weight during
pregnancy and outcomes of pregnancy.
Data synthesis Results summarised as relative risks for dichotomous
data and mean differences for continuous data.
Results We identified 44 relevant randomised controlled trials (7278
women) evaluating three categories of interventions: diet, physical
activity, and a mixed approach. Overall, there was 1.42 kg reduction
(95% confidence interval 0.95 to 1.89 kg) in gestational weight gain with
any intervention compared with control. With all interventions combined,
there were no significant differences in birth weight (mean difference
−50 g, −100 to 0 g) and the incidence of large for gestational age (relative
risk 0.85, 0.66 to 1.09) or small for gestational age (1.00, 0.78 to 1.28)
babies between the groups, though by itself physical activity was
associated with reduced birth weight (mean difference −60 g, −120 to
−10 g). Interventions were associated with a reduced the risk of
pre-eclampsia (0.74, 0.60 to 0.92) and shoulder dystocia (0.39, 0.22 to
0.70), with no significant effect on other critically important outcomes.
Dietary intervention resulted in the largest reduction in maternal
gestational weight gain (3.84 kg, 2.45 to 5.22 kg), with improved
pregnancy outcomes compared with other interventions. The overall
evidence rating was low to very low for important outcomes such as
pre-eclampsia, gestational diabetes, gestational hypertension, and
preterm delivery.
Conclusions Dietary and lifestyle interventions in pregnancy can reduce
maternal gestational weight gain and improve outcomes for both mother
and baby. Among the interventions, those based on diet are the most
effective and are associated with reductions in maternal gestational
weight gain and improved obstetric outcomes.
Introduction
Obesity is a growing threat to women of childbearing age. Half
the population is either overweight (body mass index (BMI)
25.0-29.9) or obese (BMI ≥30).
1 In Europe and the United
States, 20-40% of women gain more than the recommended
weight during pregnancy.
2 Increased maternal weight or
excessive weight gain in pregnancy is associated with adverse
pregnancy outcomes.
3 Half the women who die during
pregnancy, childbirth, or puerperium in the United Kingdom
are either obese or overweight.
4 For the offspring, maternal
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Research
RESEARCHobesity is a major risk factor for childhood obesity, which
persists into adulthood independent of other factors.
5 Obesity
costs the UK National Health Service (NHS) around £0.5bn a
year and the UK economy a further £2.3bn in indirect costs.
6
Theantenatalperiod,withopportunitiesforregularcontactwith
health professionals, is considered an ideal time to intervene as
mothers are motivated to make changes that could optimise
their outcome and that of the baby.
7 There is a need to identify
appropriateweightmanagementinterventionsthatareeffective
and safe in pregnancy. Existing reviews and guidelines are
limited in their recommendations because of the small number
of included studies.
8 9 They have not been able to identify the
best intervention that optimises the outcomes for the mother
and baby.
9 10 There is also a lack of consensus on what
constitutes important outcomes. Guidelines from the Institute
ofMedicine(IOM)providereferencerangesforoptimalweight
gain in pregnancy for normal weight, overweight, and obese
women based on observational evidence.
11 Given the potential
importance of weight management interventions in pregnancy,
we systematically reviewed the effects of dietary and lifestyle
interventions on various outcomes ranked for their importance.
Methods
We carried out systematic reviews according to protocols
developed using currently recommended review methods
12-14
and ranked outcomes for importance using a two round Delphi
survey.
15
Identification of studies
We searched Medline, Embase, BIOSIS, LILACS, Science
Citation Index, Cochrane Database of Systematic Reviews
(CDSR), Cochrane Central Register of Controlled Trials
(CENTRAL), Database of Abstracts of Reviews of Effects
(DARE),HealthTechnologyAssessmentDatabase(HTA),and
PsychInfo from inception to January 2012 to identify relevant
citations. We searched for relevant unpublished studies and
those reported in the grey literature in databases such as Inside
Conferences, Systems for Information in Grey Literature
(SIGLE),DissertationAbstracts,andClinicalTrials.gov.Internet
searches were also carried out with specialist search gateways
(suchasOMNI:www.omni.ac.uk),generalsearchengines(such
as Google), and meta-search engines (such as Copernic: www.
copernic.com). The search term combination captured the
concept“pregnancyandweight”incorporatingMeSH,freetext,
and word variants. Language restrictions were not applied.
Study selection
The electronic searches were scrutinised and full manuscripts
of all citations likely to meet the predefined selection criteria
were selected. Independent reviewers (ER and SG) examined
these manuscripts and made the final decisions regarding
inclusionorexclusion.Whendisagreementsoccurred,theywere
resolved by consensus or arbitration with a third reviewer (ST).
In cases of duplicate publication, we selected the most recent
and complete versions. Randomised controlled trials that
evaluated any dietary or lifestyle interventions with potential
toinfluencematernalandfetaloutcomesrelatedtoweightwere
included. Two independent reviewers (ER, SG) classified
interventions as mainly diet based, physical activity based, or
mixedapproach(withbothdietandphysicalactivitycomponents
that might or might not be underpinned by behavioural theory).
Any disagreements were resolved by discussion with a third
reviewer (ST). We excluded studies on pregnant women who
were underweight (BMI <18.5).
Study quality assessment and data extraction
Quality,definedastheextenttowhichanestimateofeffectwas
likely to be correct or unbiased, was evaluated with accepted
contemporarystandards.
16 17Theriskofbiasinindividualstudies
was assessed by considering six items: sequence generation,
allocation concealment, blinding, incomplete outcome data,
selectiveoutcomereporting,andotherpotentialsourcesofbias.
This information provided data for one of the domains used in
evidence rating (see below). Two independent reviewers (ER
and SG) extracted data in duplicate using predesigned and
piloted data extraction forms. We attempted to obtain missing
information by contacting investigators.
Data synthesis
We calculated relative risks with 95% confidence intervals for
dichotomous data. Continuous data were summarised as mean
differences with standard deviations. We used the I
2 statistic to
assess statistical heterogeneity between trials and explored
possible causes if we detected substantial heterogeneity (I
2
>50%). Subgroup meta-analyses for the main outcomes were
performed. For each outcome, the subgroups defined a priori
were clinical characteristics such as BMI and diabetes in
pregnancy; type of intervention; responders, defined as women
with significant reduction in gestational weight gain with
intervention; and study quality. A true subgroup effect was
considered to be present when the difference in estimates
between the subgroups was significant at P<0.005. When any
heterogeneity was not explained by subgroup analyses, we
performed meta-analysis using a random effects model. Birth
weight was analysed in kilograms and is reported in grams.
Funnel plots were used to display small study effects when the
intervention effects in smaller studies differed from the effects
displayed by larger studies. We used Egger’s test to test for
funnel plot asymmetry.
18 All analyses were carried out with
Revman
19 and Stata statistical software.
20
Prioritisation and rating of evidence
Our primary outcomes were weight related changes in the
mother and baby. We prioritised the other maternal and fetal
outcomes related to pregnancy and ranked them for importance
by a two round Delphi survey of clinicians with expertise in
this specialty.
15 Nineteen clinicians (19/20, 95% response rate)
participated in the first round and 16 (84%) in the second. The
list of outcomes ranked as critically important to weight
management in pregnancy is provided in appendix 1 on
bmj.com.
Wesummarisedthestrengthofevidenceforkeyoutcomesusing
the GRADE (grading of recommendations, assessment,
development, and evaluation) methods.
21 This system rates the
confidenceintheobservedestimateintooneoffourlevels(high,
moderate, low, and very low) evaluating five domains (risk of
bias(see above),(in-)consistency of the results(heterogeneity),
(in-)directness of the evidence, (im-)precision of the results,
and publication bias). Initially we assigned evidence from
randomisedtrialsashighqualityandreadjustedthelevelonthe
basis of deficiencies in the above domains. This lowered the
rating of evidence from high to moderate to low or even very
low, depending on the severity of the deficiency. The footnotes
in appendix 2 on bmj.com provide an explanation as to how we
downgraded evidence in the light of various deficiencies.
Safety of the interventions in pregnancy
We undertook the review of safety of interventions based on
recommended methods, including those of Cochrane adverse
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RESEARCHeffects subgroup.
22 23 We designed a separate search strategy to
evaluate safety by including text words and indexing terms for
adverseeffects.Welimitedthesearchbyincludingsearchfilters
for “adverse events”, “human studies”, and “study type”
(excluding editorials and letters). We searched Medline and
Embase from inception to March 2011. We included any
relevant randomised studies, observational studies, case series,
or case reports without any language restrictions. The number
ofadverseeventsreportedinpregnantwomenandchildrenwere
obtained for each intervention to compute a percentage of the
total number of women and children in whom the occurrence
of that particular adverse event, or confirmation of its absence,
was reported. The adverse events were quantified as relative
risks and 95% confidence intervals.
Results
Study selection
From 19 593 citations, we selected 215 full papers for
assessment(fig1⇓).Fortyfourrandomisedtrials(7278women)
reported the effects of dietary and lifestyle interventions in
pregnancy.Theinterventionsinthetrialswerebroadlyclassified
into three groups: those mainly based on diet (13 randomised
trials)
24-36 or physical activity (18 randomised trials)
37-55 and a
mixedapproachwithdietandphysicalactivitycomponentsthat
might or might not be underpinned by behavioural counselling
(13 randomised trials).
7 56-67
Characteristics of the included studies and
interventions
Theincludedtrialsstudiedtheeffectofinterventionsonwomen
with any BMI,
7 25-30 32 37-40 42-50 52 54-66 mostly obese and overweight
women,
31 33 53 or only obese women
24 29 34-36 51 59 67 (clinical
characteristics of all identified studies are in appendix 3 on
bmj.com). Five randomised trials included pregnant women
with a diagnosis of gestational diabetes mellitus
28 31 34 57 58 and
oneincludedwomenwithpre-existingdiabetes.
32Typicaldietary
interventions included a balanced diet consisting of
carbohydrates,proteins,andfatandmaintenanceofafooddiary.
Typical interventions based on physical activity included light
intensity resistance training, weight bearing exercises, and
walkingfor30minutes.Theinterventionsinthemixedapproach
includedcounsellingsessions,educationconcerningthepotential
benefit of diet and physical activity, and feedback on weight
gain in pregnancy. The mixed approach used techniques of
behavioural modification to give the women insight into
controlling periods of emotional eating and preventing binge
eating sessions. The quality of the studies varied (fig 2⇓). One
study was available only as an abstract, and data were not
included in the meta-analysis.
24
Effect of intervention on maternal weight
Thirtyfourrandomisedtrials(5481women)evaluatedtheeffect
of interventions on maternal weight gain in
pregnancy.
7 25-28 31-39 42 43 45-48 50-54 56 59-63 65-67 Compared with control
women, there was a reduction in weight gain of 1.42 kg with
interventions(95%confidenceinterval0.95to1.89kg;P<0.001,
I
2=80%) (fig 3⇓). The largest reduction in weight gain was
observed with dietary intervention (3.84 kg, 2.45 to 5.22 kg;
P<0.001, I
2=92%) (table 1⇓, fig 3⇓). There was no significant
difference between the two groups in their adherence to the
Institute of Medicine (IOM) recommended gestational target
weight gain (relative risk 0.85, 0.66 to 1.1).
Effect of intervention on fetal weight
Thirty one randomised trials (5278 newborns) evaluated the
effect of the interventions on birth
weight.
26-28 30-40 42 44-50 52 53 57 59 61-63 65 66 Compared with controls,
there was minimal reduction in the birth weight that was not
significant (mean difference −50 g, 95% confidence interval
−100 to 0 g) for all interventions (table 1⇓, fig 4⇓). There was
a trend towards reduction in the risk of large for gestational age
babies (defined as birth weight above the 90th centile or 4000
g) (relative risk 0.85, 0.66 to 1.09) with interventions (fig 5⇓.
The risk of small for gestational age babies (defined as birth
weight below the 10th centile or 2500 g) was not altered (1.00,
0.78 to 1.28) with interventions (fig 5⇓).
Effect of intervention on obstetric maternal
outcomes
Thirtysixrandomisedtrials(n=6543women)studiedtheeffect
of interventions on obstetric maternal
outcomes.
24 26 28-39 42 44-50 52-57 59 61-67 Fig 5⇓ shows the summary of
the effect of weight management interventions on pregnancy
outcomes. The overall effect of interventions led to a reduction
in pre-eclampsia by 26% (relative risk 0.74, 0.60 to 0.92;
P=0.006, I
2=31%). The summary estimate of interventions
showed trends towards reduction in gestational diabetes (0.78,
0.57 to 1.08), gestational hypertension (0.89, 0.64 to 1.25), and
preterm delivery (0.78, 0.60 to 1.02) that were not significant.
Meta-analysis of the studies showed no difference between the
groups in gestational age at delivery (mean difference 0.02
weeks, −0.08 to 0.11 weeks) and rates of caesarean section
(0.93, 0.85 to 1.01), induction of labour (1.12, 1 to 1.26), and
postpartum haemorrhage (0.90, 0.57 to 1.42).
Compared with the control, dietary interventions in pregnancy
wereassociatedwitha33%reducedriskofpre-eclampsia(0.67,
0.53 to 0.85; P<0.001, I
2=0%) and a 61% reduced risk of
gestational diabetes (0.39, 0.23 to 0.69; P=0.001, I
2=21%) (fig
6⇓). They were also associated with a significant reduction in
gestational hypertension (0.30, 0.10 to 0.88; P=0.03, I
2=0%)
andpretermdelivery(0.68,0.48to0.96;P=0.03,I
2=35%)(table
2⇓). There were no differences in these outcomes with physical
activitybasedandmixedapproachinterventionscomparedwith
the control. Visual analysis of the funnel plots showed no
evidence of small study effects for weight related outcomes.
There was some evidence for funnel asymmetry for pregnancy
outcomes such as gestational diabetes (P=0.034) and caesarean
section (P=0.002) and none for others.
Effect of interventions on fetal and neonatal
outcomes
Fifteen randomised trials (n=3905 newborns) studied the effect
of interventions on fetal and neonatal morbidity and mortality
outcomes.
28-31 34 35 37-39 46 50 53 57 63 67 Meta-analysis of the effect of
interventions showed trends towards reduction in intrauterine
death (relative risk 0.15, 0.02 to 1.20, I
2=0%), birth trauma
(0.36, 0.11 to 1.23, I
2=0%) (fig 7⇓), and hyperbilirubinaemia
(0.84, 0.64 to 1.10; table 3⇓). The overall risk of shoulder
dystocia was reduced by 61% with all interventions compared
withthecontrolgroup(0.39,0.22to0.70;P=0.002,I
2=0%;table
3⇓). There were no differences between the groups for
respiratory distress syndrome (1.05, 0.48 to 2.28), admission to
neonatal intensive care (1.00, 0.75 to 1.33), or infant
hypoglycaemia (1.07, 0.85 to 1.35) (fig 7⇓).
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RESEARCHSubgroup and sensitivity analysis
Tables 4 and 5⇓⇓ provides estimates of subgroup analyses for
clinical characteristics and quality of the included studies for
maternalandfetaloutcomes.Therewasasignificantdifference
between the subgroups for gestational weight gain based on the
type of intervention (P<0.001). The responders, defined as
women with significantly reduced gestational weight gain with
intervention,showedadifferenceinreductioninpre-eclampsia
(P=0.009) and birth weight (P=0.002) compared with the
non-responders. There were no significant differences between
the subgroups based on the BMI, diabetic status in pregnancy,
and risk of bias for allocation concealment.
When we excluded studies on women with diabetes in
pregnancy
28 31 32 34 57 58 the sensitivity analysis consistently
showed a overall reduction in gestational weight gain with
interventions(meandifference−1.4kg,95%confidenceinterval
−2.09 to −0.71 kg, P<0.001), including diet (−5.53 kg, −8.54
to −2.53 kg; P<0.001), physical activity (−0.72 kg, −1.2 to
−0.25 kg, P=0.003), and mixed approach (−1.06 kg, −1.67 to
−0.46kg;P<0.001).Therewasnosignificantreductioninbirth
weight with intervention (−40 g, −100 to 10
g).
26 27 30 33 35-40 42 44-50 52 53 59 61-63 65 66 There were no differences
between the groups in the incidence of babies who were small
orlargeforgestationalageorthosewithshoulderdystociaafter
we excluded women with diabetes. Dietary interventions in
women without diabetes resulted in a significant reduction in
pretermdelivery(relativerisk0.26,0.09to0.74)andgestational
hypertension (0.30, 0.10 to 0.88). There was a trend towards a
reduction in pre-eclampsia (0.82, 0.43 to 1.42) in these women
with diet that was not significant.
Interventionsinobeseandoverweightpregnantwomenshowed
a reduction in gestational weight gain (mean difference −2.1
kg, −3.46 to −0.75 kg; P<0.002, I
2=88%). There was no
significant reduction in fetal weight or other clinical outcomes.
Dietary intervention in obese and overweight women
significantly reduced the risk of pre-eclampsia (relative risk
0.63,0.42to0.96),gestationaldiabetes(0.39,0.23to0.69),and
gestational hypertension (0.30, 0.10 to 0.88). This benefit was
not observed for other outcomes or with other interventions.
After we excluded women with diabetes, the beneficial effect
observed with diet persisted for gestational weight gain (mean
difference −7.73 kg, −6.05 to −9.40 kg; P<0.001, I
2=41%) and
gestationalhypertension(relativerisk0.30,0.10to0.88).There
was no increase in the risk of small for gestational age babies,
and there was no effect on any of the other maternal or fetal
outcomes.
Rating the evidence
The Delphi survey of practicing clinicians determined the
importance of the maternal and fetal outcomes.
15 The overall
evidenceratingwasmoderateforreductioningestationalweight
gain (see appendix 2 on bmj.com). The rating was moderate for
evidence of no effect observed with interventions on the risk of
babieswhoweresmallforgestationalage.Theratingforclinical
outcomes such as pre-eclampsia, gestational diabetes, preterm
delivery, gestational hypertension, admission to neonatal unit,
andneonatalhypoglycaemiawaslowtoverylow.Theevidence
rating for the beneficial effect of diet was high for gestational
hypertension, moderate for gestational diabetes, low for
pre-eclampsia, and very low for preterm birth. Although
cliniciansjudgedthromboembolism,maternaladmissiontohigh
dependency or intensive care unit, and long term neurological
sequelae to the fetus as critically important outcomes, we did
not identify evidence for these outcomes.
15
Safety of the interventions
Weincluded26studiesafterreviewing14832citationstoassess
the safety of the interventions in pregnancy. Of the included
studies,twowererandomisedcontrolledtrials(277women)
40 64
and 24 were observational studies (19 cohort studies and five
case-controlstudies,468581women).
68-91Thestudiesevaluated
the effects of dietary, physical activity, and other lifestyle
interventions in pregnancy on maternal and fetal outcomes.
The two included randomised trials evaluated physical activity
and did not show an increase in meconium staining of amniotic
fluid (relative risk 0.62, 0.20 to 1.90), uterine atony (0.93, 0.22
to 3.89), or chorioamnionitis (3.69, 0.15 to 88.13). Eighteen
studies observed the effect of diet on maternal and fetal
outcomes. Most of the included studies evaluated the effect of
severe reduction in energy intake in extreme conditions such as
war or famine. There was an increase in the rate of neural tube
defectsandcleftlipandpalateinbabiesofwomenwithextreme
formsofdietingandondietswithahighglycaemicindexduring
pregnancy (see appendix 4 on bmj.com).
89 The risk of coronary
arterydisease,metabolicsyndrome,breastcancer,anddiabetes
was increased in infants born to mothers whose diet had been
severelyrestrictedbecauseoffamine.
72Therewerenosignificant
maternal or fetal adverse effects such as cord abnormalities,
threatenedmiscarriage,meconiumstainedliquor,abnormalfetal
heartratepattern,maternalsepsis,orchorioamnionitisobserved
with physical activity during pregnancy.
Discussion
Summary of the findings
Dietary and lifestyle interventions in pregnancy are effective in
reducing gestational weight gain without any adverse effect on
the risk of babies small for gestational age. Compared with
physical activity and a mixed approach, dietary interventions
were associated with the greatest reduction in weight gain in
pregnancy. Interventions also resulted in significant reduction
intheriskofpre-eclampsia.Therewasanoveralltrendtowards
reduction in gestational diabetes, gestational hypertension,
pretermbirth,andintrauterinedeathwithinterventioncompared
with control. Diet in particular, significantly reduced the risk
ofpre-eclampsia,gestationaldiabetes,gestationalhypertension,
and preterm births compared with any other intervention. The
interventionshadlesseffectonoutcomesrelatedtofetalweight
and other morbidity and mortality. Furthermore, there was no
evidence that the interventions reduced the rates of caesarean
section or induction of labour. The rating of evidence quality
wasmoderate(seeappendix2onbmj.com)forthelackofeffect
observed with interventions on size for gestational age. The
quality of evidence for the benefit observed with interventions
on gestational weight gain was moderate but low for clinical
outcomes.
Strengths and limitations
Our systematic review was comprehensive in its scope and
search. We conducted the review in line with contemporary
recommendations and complied with the PRISMA (preferred
reporting items for systematic reviews and meta-analyses)
statement.
92 Our search of literature aimed to minimise the risk
ofselectionandpublicationbias.Mostofthepublishedreviews
on effects of dietary and lifestyle interventions on maternal and
fetal outcomes were limited to specific groups of women or
types of intervention. There was no formal prioritisation of the
importanceoftheclinicaloutcomes,andfewassessedthequality
of the evidence for the important outcomes. We undertook
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RESEARCHrigorous quality assessment and formally prioritised the
outcomes for clinical importance. Reliable data were identified
on clinically important outcomes related to weight and
pregnancy by the Delphi survey. We explored for sources of
heterogeneity when required.
Appropriatesubgroupanalysesandsensitivityanalysesplanned
a priori were undertaken for important factors such as BMI,
diabetic status, maternal weight change with intervention, and
study quality that could influence outcomes. We formally rated
strengthofevidenceforkeyoutcomesidentifiedthroughDelphi
survey. This enabled our confidence in the estimates of the
importanteffectsobserved.Ourcarefulscrutinyandpresentation
ofevidenceprofilesprovidesthemuchneededclaritynecessary
to make judgments about effects.
The validity of a meta-analysis depends on the quality of the
component studies, heterogeneity observed, and the risk of
publication bias. The quality across various outcomes assessed
by GRADE was moderate for the benefit observed with
gestational weight gain but low for other important obstetric
outcomessuchaspre-eclampsia,gestationaldiabetes,gestational
hypertension,andpretermdelivery.Thisweakenstheinferences
for these outcomes. The reasons for low evidence rating were
the significant heterogeneity observed in the effect size,
deficiencies in the quality of the individual studies, and risk of
publication and related biases.
Weobservedheterogeneityforbeneficialeffectsofinterventions
on maternal weight gain that persisted after accounting for the
type of intervention, BMI, and diabetic status. Further
information is needed on characteristics of included
women—such as age, ethnicity, socioeconomic status, parity,
and underlying medical conditions—and characteristics of the
interventions—suchasfrequency,duration,andintensity—that
could influence the outcomes. We were limited in our ability
to identify the optimal weight change in pregnancy with
interventions that would minimise maternal and fetal
complications. Furthermore, constraints in the available data
limited assessment of baseline prognostic factors on the
effectiveness of outcomes. Such questions were difficult to
answer with extracted results from trial publications because
patientlevelinformationwasnotavailableandsubgroupeffects
(“treatment-covariate interactions”) were rarely reported in
sufficient detail. Although the Delphi panel of clinicians
identified long term neurological sequelae and metabolic
syndrome of the fetuses exposed to the intervention, they were
not reported in any of the studies.
Safety of the interventions
The beneficial effects observed in our review need balancing
against potential adverse effects when evaluating clinical
implications. The evidence of any adverse effects from diet in
pregnancy was usually from observational studies on extremes
of weight reduction diets or those on intake of food with a very
high or low glycaemic index.
89 These findings do not apply to
theinterventionswereviewed.Wealsoobservedthatreduction
inweightgaininpregnancywasnotassociatedwithanincrease
in babies who were small for gestational age. Observational
studies on physical activity in pregnancy did not show any
significant adverse maternal or fetal outcome for activities of
varying intensity.
Clinical and practical implications
Our findings suggest that interventions based on diet in
pregnancy would reduce the gestational weight gain by 4 kg,
on average, compared with 0.7 kg and 1.0 kg with physical
activity and a mixed approach, respectively. Dietary
interventions were most effective in reducing complications
such as pre-eclampsia, gestational diabetes, gestational
hypertension, and preterm delivery. One of the main concerns
of the mothers is the effect of dietary and lifestyle interventions
on the weight of the fetus. There is no evidence that the
interventionsevaluatedinourrevieworrecommendedincurrent
clinical practice are associated with adverse maternal or fetal
outcomes.
The diet based interventions effective in reducing weight gain
in pregnancy included a balanced diet of 18-24 kJ/kg, a low
glycaemicdietwithunprocessedwholegrains,fruits,beansand
vegetables, and a healthy diet with a maximum of 30% fat,
15-20% protein, and 50-55% carbohydrate, with energy intake
individualised to the needs of the mother. Provision of regular
inputonplannednutritionalintakefromearlypregnancythrough
dedicated dietetic teams in primary and secondary care has the
potential to improve outcomes. Overweight and obese women
benefit the most and could be targeted in clinical practice.
Current research focuses mainly on mixed interventions with
both diet and physical activity components. But interventions
predominantly based on diet seemed to be more effective for
weight related and clinical outcomes. With lack of individual
data on important factors such as age, ethnicity, socioeconomic
status, compliance, and other risk factors, we are limited in our
explanation for the benefit observed with diet compared with
other methods. There could be various reasons for this finding.
Firstly, in a complex intervention, the net benefit gained might
be linked to the vigour with which the components of the
interventionaredelivered.In“mixedapproaches”theindividual
components might not be delivered to the same standard as in
studies that focus on diet alone. Secondly, compliance might
havebeenbetterintrialswithadietonlyinterventionthanother
methods because of its relative simplicity and perceived safety
in contrast with physical activity in pregnancy.
93 94 Thirdly,
specific components of the diet, such as fibre, might have
benefits that are not evident with other interventions. Raised
triglycerideconcentrationsinpregnancyareassociatedwiththe
risk of pre-eclampsia.
95 There is a known reduction in the
incidence of pre-eclampsia by up to 70% associated with a fall
intheconcentrationsoftriglyceridesinwomenwiththehighest
quarterofdietaryfibreintakecomparedwiththelowestquarter
after adjustment for confounders.
96 The high fibre in the dietary
intervention of the included studies could have influenced the
beneficial effect observed with reduction in the rates of
pre-eclampsia.
The economic evaluation undertaken by the National Institute
for Health and Clinical Excellence on non-pharmacological
interventionsforweightmanagementoutsidepregnancyreported
that diet based interventions were cheaper than interventions
basedonphysicalactivity.
97Withtheclearbenefitingestational
weight gain observed with dietary interventions in pregnancy,
there is a potential for this strategy to be also cost effective
compared with other methods.
Recommendations for future research
Synthesis of patient level data by individual patient data
meta-analysis is needed to assess any differential effect of the
benefits observed with interventions in various groups based
on BMI, age, ethnicity, socioeconomic status, parity, and risk
status in pregnancy. Availability of the raw data will
substantially increase the power to detect baseline factors that
trulymodifytheinterventioneffect
98andwillenableintervention
effects to be quantified for clinically relevant groups.
99 In
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RESEARCHaddition, individual patient data meta-analysis will be able to
assess whether the improvement in clinical outcomes is related
to reduction in gestational weight gain alone or if there is any
added benefit from the type of intervention resulting in weight
change. It will also allow the magnitude of benefit from weight
change in pregnancy to be quantified for both the mother and
baby.Thiswillallowustoimplementthoseweightmanagement
interventions that show clear benefit with specific weight gain
targets in pregnancy. This approach will also provide adequate
power to generate valid, reliable answers and to populate the
model for decision analytic modelling for health economic
evaluation.
The paucity of descriptive information on the intensity and
duration of intervention, means of provision, and patient
compliancearefactorsthatcouldpotentiallyfacilitateorhinder
implementation.Thesegapsidentifyissuesforfurtherresearch.
There is a need for good quality large prospective studies for
the important clinical outcomes identified including long term
effects on the mother and fetus.
Conclusion
Until now, the recommendations for weight management in
pregnancyhavemainlyfocusedonobeseandoverweightwomen
withoutanemphasisonaparticulartypeofintervention.Dietary
interventioniseffective,safe,andpotentiallycosteffectiveand
dominates physical activity based intervention. The case for its
introductionwithaserviceevaluationalongsideisunderpinned
by our review. Ongoing effectiveness trials should focus on
clinically relevant outcomes captured by our Delphi survey.
They should generate data for determining the most efficient
means for improving outcomes with weight management
strategies in pregnancy.
Contributors: ST, AC, and KSK developed the protocol with input from
other authors. ER and SG performed the search, study selection, and
data extraction. ER, SG, and ST analysed the results. ST, AC, and KSK
drafted the manuscript. AC and KSK contributed equally to the
manuscript. All authors provided input into the development of the
manuscript. ST is guarantor.
Funding: This study was funded by the National Institute for Health
Research (NIHR) HTA (Health Technology Assessment) UK programme
09/27/06. The views and opinions expressed therein are those of the
authors and do not necessarily reflect those of the HTA programme,
NIHR, NHS, or the Department of Health.
Competing interest: All authors have completed the ICMJE uniform
disclosure form at www.icmje.org/coi_disclosure.pdf (available on
request from the corresponding author) and declare: no support from
any organisation for the submitted work; no financial relationships with
any organisations that might have an interest in the submitted work in
the previous three years; no other relationships or activities that could
appear to have influenced the submitted work.
Ethical approval: Not required.
Data sharing: No additional data available.
1 NHS Information Centre. Health survey for England 2006: CVD and risk factors adults,
obesity and risk factors children. NHS Information Centre, 2008.
2 Thangaratinam S, Jolly K. Obesity in pregnancy: a review of reviews on the effectiveness
of interventions. BJOG 2010;117:1309-12.
3 Ramachendran J, Bradford J, McLean J. Maternal obesity and pregnancy complications:
a review. Aust N Z J Obstet Gynaecol 2008;48:228-45.
4 Lewis G. The Confidential Enquiry into Maternal and Child Health (CEMACH). Saving
mothers’ lives: reviewing maternal deaths to make motherhood safer. The seventh report
of the confidential enquiries into maternal deaths in the United Kingdom. CEMACH, 2007.
5 Drake AJ, Reynolds RM. Impact of maternal obesity on offspring obesity and
cardiometabolic disease risk. Reproduction 2010;140:387-98.
6 National Audit Office. Tackling obesity in England. Stationery Office, 2001.
7 Jackson RA, Stotland NE, Caughey AB, Gerbert B. Improving diet and exercise in
pregnancy with Video Doctor counseling: a randomized trial. Patient Educ Couns
2011;83:203-9.
8 NICE. Public health guidance 27. Dietary interventions and physical activity interventions
for weight management before, during and after pregnancy. National Institute for Health
and Clinical Excellence, 2010.
9 Streuling I, Beyerlein A, von Kries. Can gestational weight gain be modified by increasing
physical activity and diet counselling? A meta-analysis of interventional trials. Am J Clin
Nutr 2010;92:678-87.
10 Campbell F, Messina J, Johnson M, Guillaume L, Madan J, Goyder E. Systematic review
of dietary and/or physical activity interventions for weight management in pregnancy.
NICE Centre for Public Health Excellence, 2009.
11 Rasmussen KM, Yatkine AL, eds. Weight gain during pregnancy: re-examining the
guidelines. Committee to Reexamine Institute of Medicine Pregnancy Weight Guidelines
2009.
12 Higgins JPT, Green S. Cochrane handbook for systematic reviews of interventions. Version
5.0.1. Cochrane Collaboration, 2008.
13 Khan KS, ter Riet G, Glanville J, Sowden AJ, Kleijnen J. Undertaking systematic reviews
of research on effectiveness. CRD’s guidance for carrying out or commissioning reviews.
2nd ed. NHS Centre for Reviews and Dissemination, University of York, 2001.
14 Khan KS, Kunz R, Kleijnen J, Antes G. Systematic reviews to support evidence-based
medicine: how to review and apply findings of systematic reviews. Br J Anaesth
2003;91:767-8.
15 Thangaratinam S, Rogozinska E, Jolly K, Glinkowski S, Duda W, Borowiack E, et al.
Interventions to reduce or prevent obesity in pregnant women: a systematic review. Health
Technol Assess (in press).
16 Glasziou P, Chalmers I, Altman D, Bastian H, Boutron I, Brice A, et al. Taking healthcare
interventions from trial to practice. BMJ 2010;341:c3852.
17 Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Schunemenn HJ. GRADE: What
is “quality of evidence” and why is it important to clinicians? BMJ 2008;336:995-8.
18 Sterne JAC, Egger M, Smith GD. Systematic reviews in health care: investigating and
dealing with publication and other biases in meta-analysis. BMJ 2001;323:101-5.
19 Review Manager (Computer program). Version 5.1. Nordic Cochrane Centre. Cochrane
Collaboration, 2011.
20 StataCorp. Stata Statistical Software: release 8. StataCorp LP, 2003.
21 Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. GRADE:
an emerging consensus on rating quality of evidence and strength of recommendations.
BMJ 2008;336:924-6.
22 Cochrane Adverse Effects Sub-Group of the Cochrane Non-Randomised Study Methods
Group. Including adverse effects in systematic reviews: interim recommendations.
Cochrane Group, 2011.
23 Loke YK, Price D, Herxheimer A. Systematic reviews of adverse effects: framework for
a structured approach. BMC Med Res Methodol 2007;7:32.
24 Badrawi H, Hassanein MK, Badraoui MHH, Wafa YA, Shawky HA, Badrawi N. Pregnancy
outcome in obese pregnant mothers. J Perinat Med 1992;20:203.
25 Bechtel-Blackwell DA. Computer-assisted self-interview and nutrition education in pregnant
teens. Clin Nurs Res 2002;11:450-62.
26 Briley C, Flanagan NL, Lewis N. In-home prenatal nutrition intervention increased dietary
iron intakes and reduced low birthweight in low-income African-American women. J Am
Diet Assoc 2002;102:984-7.
27 Clapp IJF. Diet, exercise, and fete-placental growth. Arch Gynecol Obstet 1997;260:101-8.
28 Crowther CA, Hiller JE, Moss JR, McPhee AJ, Jeffries WS, Robinson JS. Effect of
treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med
2005;352:2477-86.
29 Gomez TG, Delgado JG, Agudelo AA, Hurtado H. Diet effects on the perinatal result of
obese pregnant patient. [Spanish]. Rev Colomb Obstet Ginecol 1994;45:313-6.
30 Khoury J, Henriksen T, Christophersen B, Tonstad S. Effect of a cholesterol-lowering diet
on maternal, cord, and neonatal lipids, and pregnancy outcome: a randomized clinical
trial. Am J Obstet Gynecol 2005;193:1292-301.
31 Landon MB, Spong CY, Thom E, Carpenter MW, Ramin SM, Casey B, et al. A multicenter,
randomized trial of treatment for mild gestational diabetes. N Engl J Med
2009;361:1339-48.
32 Ney D, Hollingsworth DR, Cousins L. Decreased insulin requirement and improved control
of diabetes in pregnant women given a high-carbohydrate, high-fiber, low-fat diet. Diabetes
Care 1982;5:529-33.
33 Quinlivan JA, Lam LT, Fisher J. A randomised trial of a four-step multidisciplinary approach
to the antenatal care of obese pregnant women. Aust N Z J Obstet Gynaecol
2011;51:141-6.
34 Rae A, Bond D, Evans S, North F, Roberman B, Walters B. A randomised controlled trial
of dietary energy restriction in the management of obese women with gestational diabetes.
Aust N Z J Obstet Gynaecol 2000;40:416-22.
35 Thornton YS, Smarkola C, Kopacz SM, Ishoof SB. Perinatal outcomes in nutritionally
monitored obese pregnant women: a randomized clinical trial. J Natl Med Assoc
2009;101:569-77.
36 Wolff S, Legarth J, Vangsgaard K, Toubro S, Astrup A. A randomized trial of the effects
of dietary counseling on gestational weight gain and glucose metabolism in obese pregnant
women. Int J Obes 2008;32:495-501.
37 Baciuk EP, Pereira RI, Cecatti JG, Braga AF, Cavalcante SR. Water aerobics in pregnancy:
cardiovascular response, labor and neonatal outcomes. Reprod Health 2008;5:10.
38 Barakat R, Lucia A, Ruiz JR. Resistance exercise training during pregnancy and newborn’s
birth size: a randomised controlled trial. Int J Obes 2009;33:1048-57.
39 Barakat R, Cordero Y, Coteron J, Luaces M, Montejo R. Exercise during pregnancy
improves maternal glucose screen at 24-28 weeks: a randomised controlled trial. Br J
Sports Med 2011 Sep 26, epub ahead of print.
40 Bell RJ, Palma SM. Antenatal exercise and birth-weight. Aust N Z J Obstet Gynaecol
2000;40:70-3.
41 Cavalcante SR, Cecatti JG, Pereira RI, Baciuk EP, Bernardo AL, Silveira C. Water aerobics
II: maternal body composition and perinatal outcomes after a program for low risk pregnant
women. Reprod Health 2009;6:1.
42 Clapp JF, III, Kim H, Burciu B, Lopez B. Beginning regular exercise in early pregnancy:
effect on fetoplacental growth. Am J Obstet Gynecol 2000;183:1484-8.
43 Erkkola R. The influence of physical exercise during pregnancy upon physical work
capacity and circulatory parameters. Scand J Clin Lab Invest 1976;6:747-9.
44 Erkkola R, Makela M. Heart volume and physical fitness of parturients. Ann Clin Res
1976;8:15-21.
45 Garshasbi A, Faghih ZS. The effect of exercise on the intensity of low back pain in pregnant
women. Int J Gynaecol Obstet 2005;88:271-5.
No commercial reuse: See rights and reprints http://www.bmj.com/permissions Subscribe: http://www.bmj.com/subscribe
BMJ 2012;344:e2088 doi: 10.1136/bmj.e2088 (Published 17 May 2012) Page 6 of 15
RESEARCHWhat is already known on this topic
Excessive weight gain in pregnancy is associated with adverse maternal and fetal outcomes
Interventions to manage weight in pregnancy have the potential to reduce adverse outcomes to mother and baby
Interventions based on diet or physical activity, or both, in pregnancy could influence maternal and fetal weight and obstetric outcomes
What this study adds
Diet and lifestyle interventions in pregnancy can reduce maternal weight gain in pregnancy
There is no significant overall effect on outcomes related to fetal weight
Diet based interventions are the most effective in reducing maternal gestational weight gain compared with other methods
46 Haakstad L, Bo K. Exercise in pregnant women and birth weight: a randomized controlled
trial. BMC Preg Childbirth 2011;11:66.
47 Hopkins SA, Baldi JC, Cutfield WS, McCowan L, Hofman PL. Exercise training in
pregnancy reduces offspring size without changes in maternal insulin sensitivity. J Clin
Endocrinol Metab 2010;95:2080-8.
48 Khaledan A, Sh, Motahari Tabari NS, Ahmad Shirvani M. Effect of an aerobic exercise
program on fetal growth in pregnant women. HAYAT: J Faculty Nurs Midwifery 2010;16:78.
49 Lee G, Challenger S, McNabb M, Sheridan M. Exercise in pregnancy. Mod Midwife
1996;6:28-33.
50 Marquez-Sterling S, Perry AC, Kaplan TA, Halberstein RA, Signorile JF. Physical and
psychological changes with vigorous exercise in sedentary primigravidae. Med Sci Sports
Exerc 2000;32:58-62.
51 Ong MJ, Guelfi KJ, Hunter T, Wallman KE, Fournier PA, Newnham JP. Supervised
home-based exercise may attenuate the decline of glucose tolerance in obese pregnant
women. Diabetes Metab 2009;35:418-21.
52 Prevedel T, Calderon I, DM, Adami H-O, RM. Maternal and perinatal effects of
hydrotherapy in pregnancy. Rev Bras Ginecol Obstet 2003;25:53-9.
53 Santos IA, Stein R, Fuchs SC, Duncan BB, Ribeiro JP, Kroeff LR, et al. Aerobic exercise
and submaximal functional capacity in overweight pregnant women: a randomized trial.
Obstet Gynecol 2005;106:243-9.
54 Sedaghati P, Ziaee V, Ardjmand A. The effect of an ergometric training program on
pregnants weight gain and low back pain. Gazzetta Medica Italiana Archivio per le Scienze
Mediche 2007;166:209-13.
55 Yeo S, Steele NM, Chang MC, Leclaire SM, Ronis DL, Hayashi R. Effect of exercise on
blood pressure in pregnant women with a high risk of gestational hypertensive disorders.
J Reprod Med 2000;45:293-8.
56 Asbee SM, Jenkins TR, Butler JR, White J, Elliot M, Rutledge A. Preventing excessive
weight gain during pregnancy through dietary and lifestyle counseling: a randomized
controlled trial. Obstet Gynecol 2009;113:305-12.
57 Bung P, Artal R, Khodiguian N, Kjos S. Exercise in gestational diabetes. An optional
therapeutic approach? Diabetes 1991;40(suppl 2):182-5.
58 Ferrara A, Hedderson MM, Albright CL, Ehrlich SF, Quesenbery CP, Peng TP, et al. A
pregnancy and postpartum lifestyle intervention in women with gestational diabetes mellitus
reduces diabetes risk factors. A feasibility randomized control trial. Diabetes Care
2011;34:1519-25.
59 Guelinckx I, Devlieger R, Mullie P, Vansant G. Effect of lifestyle intervention on dietary
habits, physical activity, and gestational weight gain in obese pregnant women: a
randomized controlled trial. Am J Clin Nutr 2010;91:373-80.
60 Huang TT, Yeh CY, Tsai YC. A diet and physical activity intervention for preventing weight
retention among Taiwanese childbearing women: a randomised controlled trial. Midwifery
2011;27:257-64.
61 Hui A, Back L, Ludwig S, Gardiner P, Sevenhuysen G, Dean H, et al. Lifestyle intervention
on diet and exercise reduced excessive gestational weight gain in pregnant women under
a randomised controlled trial. BJOG 2011;119:70-7.
62 Hui AL, Ludwig SM, Gardiner P, Sevenhuysen G, Murray R, Morris M, et al.
Community-based exercise and dietary intervention during pregnancy: a pilot study. Can
J Diabetes 2006;30:169-75.
63 Jeffries K, Shub A, Walker SP, Hiscock R, Permezel M. Reducing excessive weight gain
in pregnancy: a randomised controlled trial. Med J Aust 2009;191:429-33.
64 Kulpa PJ, White BM, Visscher R. Aerobic exercise in pregnancy. Am J Obstet Gynecol
1987;156:1395-403.
65 Phelan S, Phipps MG, Abrams B, Darroch F, Schaffner A, Wing RR. Randomized trial of
a behavioral intervention to prevent excessive gestational weight gain: the Fit for Delivery
Study. Am J Clin Nutr 2011;93:772-9.
66 Polley BA, Wing RR, Sims CJ. Randomized controlled trial to prevent excessive weight
gain in pregnant women. Int J Obes 2002;26:1494-502.
67 Vinter CA, Jensen DM, Ovesen P, Beck-Nielsen H, Jorgensen JS. The LiP (Lifestyle in
Pregnancy) study: a randomized controlled trial of lifestyle intervention in 360 obese
pregnant women. Diabetes Care 2011;34:2502-7.
68 Carmichael SL, Shaw GM, Schaffer DM, Laurent C, Selvin S. Dieting behaviors and risk
of neural tube defects. Am J Epidemiol 2003;158:1127-31.
69 Clapp JF, III. The course of labor after endurance exercise during pregnancy. Am J Obstet
Gynecol 1990;163:1799-805.
70 Clapp JF, III, Capeless EL. Neonatal morphometrics after endurance exercise during
pregnancy. Am Obstet Gynecol 1990;163:1805-11.
71 Dale E, Mullinax KM, Bryan DH. Exercise during pregnancy: effects on the fetus. C J Appl
Sport Sci 1982;7:98-103.
72 De Rooij SR, Painter RC, Holleman F, Bossuyt PM, Roseboom TJ. The metabolic
syndrome in adults prenatally exposed to the Dutch famine. Am J Clin Nutr
2007;86:1219-24.
73 Gregory PB, Rush D. Iatrogenic caloric restriction in pregnancy and birthweight. Am J
Perinatol 1987;4:365-71.
74 Hatch MC, Shu XO, McLean DE, Levin B, Begg M, Reuss L, et al. Maternal exercise
during pregnancy, physical fitness, and fetal growth. Am J Epidemiol 1993;137:1105-14.
75 Knudsen VK, Orozova-Bekkevold IM, Mikkelsen TB, Wolff S, Olsen SF. Major dietary
patterns in pregnancy and fetal growth. Eur J Clin Nutr 2008;62:463-70.
76 Lenders CM, Hediger ML, Scholl TO, Khoo CS, Slap GB, Stallings VA. Effect of high-sugar
intake by low-income pregnant adolescents on infant birth weight. J Adolesc Health
1994;15:596-602.
77 Lenders CM, Hediger ML, Scholl TO, Khoo CS, Slap GB, Stallings VA. Gestational age
and infant size at birth are associated with dietary sugar intake among pregnant
adolescents. J Nutr 1997;127:1113-7.
78 Lumey LH, Stein AD, Kahn HS, Romijn JA. Lipid profiles in middle-aged men and women
after famine exposure during gestation: the Dutch Hunger Winter Families Study. Am J
Clin Nutr 2009;89:1737-43.
79 Magann EF, Evans SF, Weitz B, Newnham J. Antepartum, intrapartum, and neonatal
significance of exercise on healthy low-risk pregnant working women. Obstet Gynecol
2002;99:466-72.
80 Neugebauer R, Hoek HW, Susser E. Prenatal exposure to wartime famine and
development of antisocial personality disorder in early adulthood. JAMA 1999;282:455-62.
81 Ravelli AC, van der Meulen JH, Michels RP, Osmond C, Barker DJ, Hales CN, et al.
Glucose tolerance in adults after prenatal exposure to famine. Lancet 1998;351:173-7.
82 Ravelli GP, Stein ZA, Susser MW. Obesity in young men after famine exposure in utero
and early infancy. N Engl J Med 1976;295:349-53.
83 Roseboom TJ, van der Meulen JH, Osmond C, Barker DJ, Ravelli AC, Bleker OP. Plasma
lipid profiles in adults after prenatal exposure to the Dutch famine. Am J Clin Nutr
2000;72:1101-6.
84 Roseboom TJ, van der Meulen JH, Osmond C, Barker DJ, Ravelli AC, Schroeder-Tanka
JM, et al. Coronary heart disease after prenatal exposure to the Dutch famine, 1944-45.
Heart 2000;84:595-8.
85 Schramm WF, Stockbauer JW, Hoffman HJ. Exercise, employment, other daily activities,
and adverse pregnancy outcomes. Am J Epidemiol 1996;143:211-8.
86 Stanner SA, K Bulmer, C Andrès, O E Lantseva, V Borodina, V V Poteen, et al. Does
malnutrition in utero determine diabetes and coronaryè heart disease in adulthood?
Results from the Leningrad siege study, a cross sectional study. BMJ 1997;315:1342-8.
87 Stein AD, Kahn HS, Rundle A, Zybert PA, van der Pal-de Bruin, Lumey LH. Anthropometric
measures in middle age after exposure to famine during gestation: evidence from the
Dutch famine. Am J Clin Nutr 2007;85:869-76.
88 Vujkovic M, Ocke MC, Van Der Spek PJ, Yazdanpanah N, Steegers EA,
Steegers-Theunissen RP. Maternal western dietary patterns and the risk of developing
a cleft lip with or without a cleft palate. Obstet Gynecol 2007;110:378-84.
89 Yazdy MM, Liu S, Mitchell AA, Werler MM. Maternal dietary glycemic intake and the risk
of neural tube defects. Am J Epidemiol 2010;171:407-14.
90 Painter RC, De R, Sr., Bossuyt PM, Osmond C, Barker DJ, Bleker OP, et al. A possible
link between prenatal exposure to famine and breast cancer: a preliminary study. Am J
Hum Biol 2006;18:853-6.
91 De Rooij SR, Painter RC, Phillips DI, Osmond C, Tanck MW, Bossuyt PM, et al. Cortisol
responses to psychological stress in adults after prenatal exposure to the Dutch famine.
Psychoneuroendocrinology 2006;31:1257-65.
92 Moher D, Liberati A, Tetzlaff J, Altman DG, for the PRISMA group. Preferred reporting
items for systematic reviews and meta-analyses: the PRISMA statement. BMJ
2009;339:b2535.
93 Clarke PE, Gross H. Women’s behaviour, beliefs and information sources about physical
exercise in pregnancy. Midwifery 2009;20:133-41.
94 Gross H, Bee PE. Perceptions of effective advice in pregnancy. The case of activity. Clin
Eff Nurs 2004;8:161-9.
95 Ray JG, Diamond P, Singh G, Bell CM. Brief overview of maternal triglycerides as a risk
factor for pre-eclampsia. BJOG 2006;113:379-86.
96 Qiu C, Coughlin KB, Frederick IO, Sorensen TK, Williams MA. Dietary fiber intake in early
pregnancy and risk of subsequent preeclampsia. Am J Hypertens 2008;21:903-9.
97 NICE clinical guideline 43. Obesity. NICE, 2006. www.nice.org.uk/guidance/CG43.
98 Lambert PC, Sutton RJ, Abrams KR, Jones DR. A comparison of summary patient-level
covariates in meta-regression with individual patient data meta-analysis. Clin Epidemiol
2002;55:86-94.
99 Thomson SG, Higgins JP. Treating individuals 4: can meta-analysis help target
interventions at individuals most likely to benefit? Lancet 2005;365:341-6.
Accepted: 2 March 2012
Cite this as: BMJ 2012;344:e2088
This is an open-access article distributed under the terms of the Creative Commons
Attribution Non-commercial License, which permits use, distribution, and reproduction in
any medium, provided the original work is properly cited, the use is non commercial and
is otherwise in compliance with the license. See: http://creativecommons.org/licenses/by-
nc/2.0/ and http://creativecommons.org/licenses/by-nc/2.0/legalcode.
No commercial reuse: See rights and reprints http://www.bmj.com/permissions Subscribe: http://www.bmj.com/subscribe
BMJ 2012;344:e2088 doi: 10.1136/bmj.e2088 (Published 17 May 2012) Page 7 of 15
RESEARCHTables
Table 1 | Effect of dietary and lifestyle interventions in pregnancy on primary outcomes (weight gain in pregnancy and birth weight) and
secondary weight related outcomes ranked as critically important by Delphi survey (except for exceeding IOM recommendations)
I
2 (%) P value Summary estimate (95% CI) No of participants No of studies
Dietary intervention
92 <0.001 −3.84* (−5.22 to −2.45) 2560 10
25-28 31-36 Weight gain in pregnancy (kg)
84 0.41 −60* (−190 to 80) 2861 10
26-28 30-36 Birth weight (g)
0 0.91 1.02† (0.75 to 1.37) 2252 3
28 30 31 Small for gestational age
63 0.26 0.78† (0.51 to 1.19) 2378 5
28 29 31 34 35 Large for gestational age
— — — — 0 Exceeds IOM recommendations
Physical activity
30 0.003 −0.72* (−1.20 to −0.25) 1057 14
37-39 42 43 45-48 50-54 Weight gain in pregnancy (kg)
0 0.02 −60* (−120 to −10) 1369 14
37-40 42 44-50 52 53 Birth weight (g)
0 0.60 1.28† (0.52 to 3.15) 409 4
37 38 46 53 Small for gestational age
0 0.08 0.52† (0.25 to 1.09) 355 4
38 39 46 52 Large for gestational age
NA 0.05 0.33† (0.11 to 0.98) 74 1
46 Exceeds IOM recommendations
Mixed approach
36 <0.001 −1.06* (−1.67 to −0.46) 1864 10
7 56 59-63 65-67 Weight gain in pregnancy (kg)
0 0.86 10* (−50 to 70) 1048 7
57 59 61-63 65 66 Birth weight (g)
0 0.60 0.88† (0.53 to 1.44) 891 4
58 63 65 66 Small for gestational age
0 0.72 1.05† (0.79 to 1.40) 1500 9
57-59 61 62 63 65-67 Large for gestational age
56 0.33 0.89† (0.71 to 1.13) 899 4
61 63 65 66 Exceeds IOM recommendations
All interventions
80 <0.001 −1.42* (−1.89 to −0.95) 5481 34 Weight gain in pregnancy (kg)
57 0.08 −50* (−100 to 0) 5278 31 Birth weight (g)
0 0.99 1.00† (0.78 to 1.28) 3552 11 Small for gestational age
38 0.21 0.85† (0.66 to 1.09) 4233 18 Large for gestational age
60 0.21 0.85† (0.66 to 1.11) 873 5 Exceeds IOM recommendations
IOM=Institute of Medicine; NA=not applicable.
*Mean difference.
†Relative risk.
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RESEARCHTable 2| Effect of dietary and lifestyle interventions in pregnancy on secondary maternal outcomes (ranked as critically important by Delphi
survey, except for vaginal delivery and gestational age at birth). Summary estimates are relative risks unless stated otherwise
I
2 (%) P value Summary estimate (95% CI) No of participants No of studies
Dietary intervention
21 0.001 0.39 (0.23 to 0.69) 409 3
33 35 36 Gestational diabetes mellitus
0 <0.001 0.67 (0.53 to 0.85) 2624 6
28 30 31 34-36 Pre-eclampsia
0 0.03 0.30 (0.10 to 0.88) 282 2
35 36 Gestational hypertension
35 0.03 0.68 (0.48 to 0.96) 1474 4
26 30 31 35 Preterm delivery
49 0.19 0.93 (0.84 to1.04) 2273 5
28 29 31 35 36 Caesarean section
0 0.56 0.97 0.89 to 1.07) 472 2
31 34 Vaginal delivery
60 0.07 1.12 (0.99 to 1.27) 2277 4
28 31 34 35 Induction of labour
0 0.64 0.90 (0.57 to 1.42) 1232 2
28 35 Postpartum haemorrhage
71 0.42 −0.05* (−0.18 to 0.08) 2625 6
28 30-32 34 35 Gestational age at delivery (weeks)
Physical activity
— — — — 0 Gestational diabetes mellitus
— — — — 0 Pre-eclampsia
— — — — 0 Gestational hypertension
0 0.65 1.22 (0.51 to 2.90) 450 5
37 38 46 52 53 Preterm delivery
0 0.38 0.88 (0.66 to 1.17) 542 5
37 39 48-50 Caesarean section
0 0.70 1.02 (0.93 to 1.11) 488 3
37 39 49 Vaginal delivery
— — — — 0 Induction of labour
— — — — 0 Postpartum haemorrhage
0 0.74 0.03* (−0.14 to 0.20) 1250 11
37-39 42 44-49 54 Gestational age at delivery (weeks)
Mixed approach
0 0.44 1.18 (0.78 to 1.77) 1233 6
61 62 63 65-67 Gestational diabetes mellitus
39 0.57 1.16 (0.70 to 1.90) 718 4
59 63 65 66 Pre-eclampsia
42 0.69 1.08 (0.75 to 1.55) 779 4
59 63 65 66 Gestational hypertension
7 0.68 0.90 (0.55 to 1.47) 728 4
57 63 65 66 Preterm delivery
10 0.53 0.94 (0.79 to 1.13) 1407 8
56 57 59 61 63 65-67 Caesarean section
NA 0.21 1.25 (0.88 to 1.78) 34 1
57 Vaginal delivery
NA 0.44 1.17 (0.78 to 1.75) 85 1
59 Induction of labour
— — — — 0 Postpartum haemorrhage
1 0.07 0.20* (−0.02 to 0.42) 813 6
57 59 61 62 65 66 Gestational age at delivery (weeks)
All interventions
29 0.13 0.78 (0.57 to 1.08) 1642 9 Gestational diabetes mellitus
31 0.006 0.74 (0.60 to 0.92) 3342 10 Pre-eclampsia
50 0.51 0.89 (0.64 to 1.25) 1061 6 Gestational hypertension
0 0.07 0.78 (0.60 to 1.02) 2652 13 Preterm delivery
3 0.10 0.93 (0.85 to 1.01) 4222 18 Caesarean section
0 0.91 1.00 (0.94 to 1.07) 994 6 Vaginal delivery
47 0.05 1.12 (1.00 to 1.26) 2362 5 Induction of labour
0 0.64 0.90 (0.57 to 1.42) 1232 2 Postpartum haemorrhage
33 0.72 0.02* (−0.08 to 0.11) 4688 23 Gestational age at delivery (weeks)
NA=not applicable.
*Mean difference.
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RESEARCHTable 3| Effect of dietary and lifestyle interventions in pregnancy* on secondary fetal and neonatal outcomes (ranked as critically important
by Delphi survey, except for infant hyperbilirubinaemia). Summary estimates are relative risks unless stated otherwise
I
2 (%) P value Relative risk (95% CI) No of participants No of studies
Dietary intervention
0 0.07 0.15 (0.02 to 1.20) 1320 2
28 30 Intrauterine death
77 0.93 0.98 (0.66 to 1.47) 1962 2
28 31 Admission to neonatal intensive care unit
0 0.001 0.38 (0.21 to 0.69) 2082 3
28 31 34 Shoulder dystocia
0 0.10 0.36 (0.11 to 1.23) 1961 2
28 31 Birth trauma
58 0.91 1.05 (0.48 to 2.28) 1962 2
28 31 Respiratory distress syndrome
41 0.69 1.05 (0.83 to 1.33) 1877 3
28 31 34 Infant hypoglycaemia
0 0.19 0.84 (0.64 to 1.10) 1898 2
28 31 Infant hyperbilirubinaemia
Mixed approach
— — — — 0 Intrauterine death
NA 0.94 0.98 (0.56 to 1.71) 304 1
67 Admission to neonatal intensive care unit
NA 0.94 0.90 (0.06 to 14.14) 235 1
63 Shoulder dystocia
— — — — 0 Birth trauma
— — — — 0 Respiratory distress syndrome
0 0.3 2.35 (0.47 to 11.76) 269 2
57 63 Infant hypoglycaemia
— — — — 0 Infant hyperbilirubinaemia
All interventions
0 0.07 0.15 (0.02 to 1.20) 1320 2 Intrauterine death
58 1.00 1.00 (0.75 to 1.33) 2266 3 Admission to neonatal intensive care unit
0 0.002 0.39 (0.22 to 0.70) 2317 4 Shoulder dystocia
0 0.10 0.36 (0.11 to 1.23) 1961 2 Birth trauma
58 0.91 1.05 (0.48 to 2.28) 1962 2 Respiratory distress syndrome
10 0.55 1.07 (0.85 to 1.35) 2146 5 Infant hypoglycaemia
0 0.19 0.84 (0.64 to 1.10) 1898 2 Infant hyperbilirubinaemia
*No randomised studies evaluated effect of physical activity for above outcomes.
NA=not applicable.
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RESEARCHTable 4| Subgroup analyses for trial methods and clinical characteristics for maternal outcomes in evaluation of dietary and lifestyle
interventions in pregnancy
Pre-eclampsia Gestational weight gain (kg)
Subgroup
P value for
interaction Relative risk (95% CI) No of studies
P value for
interaction Mean difference (95% CI) No of studies
Intervention type:
0.05 0.67 (0.53 to 0.85) 6 <0.001 −3.84 (−5.22 to −2.45) 10 Diet
— 0 −0.72 (−1.20 to −0.25) 14 Physical activity
1.16 (0.70 to 1.90) 4 −1.06 (−1.67 to −0.46) 10 Mixed
Diabetic status:
0.06 0.65 (0.50 to 0.84) 3 0.33 −1.85 (−2.44 to −1.26) 4 Women with diabetes
1.01 (0.68 to 1.50) 7 −1.4 (−2.09 to −0.71) 30 Normal women
BMI:
0.49 0.81 (0.58 to 1.14) 7† 0.05 −2.41 (−4.04 to -0.77) 11*† Obese and overweight
0.70 (0.53 to 0.92) 4† −0.63 (−1.24 to -0.02) 25*† Any weight
Maternal weight change with intervention:
0.009 0.61 (0.47 to 0.79) 4 — — — Significantly reduced
1.12 (0.77 to 1.61) 6 — — No significant change
Risk of bias (allocation concealment):
0.76 0.73 (0.56 to 0.93) 7 0.07 −0.89 (−1.61 to −0.17) 28 High risk
0.78 (0.53 to 1.16) 3 −2.14 (−3.28 to −1.01) 6 Low risk
*Polley et al
66 data presented separately for normal weight women and overweight women.
†Phelan 2011 et al
65 data presented separately for normal weight women and overweight women.
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RESEARCHTable 5| Subgroup analyses for trial methods and clinical characteristics for fetal outcomes in evaluation of dietary and lifestyle interventions
in pregnancy
Small for gestational age Large for gestational age Birth weight (g)
Subgroup
P value for
interaction
Relative risk (95%
CI)
No of
studies
P value for
interaction
Relative risk (95%
CI)
No of
studies
P value for
interaction
Mean difference
(95% CI)
No of
studies
Intervention type:
0.76 1.02 (0.75 to 1.37) 3 0.16 0.78 (0.51 to 1.19) 5 0.22 −60 (−190 to 80) 10 Diet
1.28 (0.52 to 3.15) 4 0.52 (0.25 to 1.09) 4 −60 (−120 to −10) 14 Physical
activity
0.88 (0.53 to 1.44) 4 1.05 (0.79 to 1.40) 9 10 (−50 to 70) 7 Mixed
Diabetic status:
0.77 1.03 (0.75 to 1.41) 3 0.34 0.97(0.73 to 1.27) 13 0.80 −60 (−170 to 50) 5 Women with
diabetes
0.95 (0.64 to 1.42) 8 0.76 (0.50 to 1.15) 5 −40 (−100 to 10) 26 Normal
women
BMI:
0.35 1.17 (0.77 to 1.80) 4*† 0.13 1.05 (0.68 to 1.63) 7† 0.43 −20 (−90 to 50) 9* Obese and
overweight
0.92 (0.68 to 1.24) 9*† 0.71 (0.55 to 0.91) 12† −60 (−130 to 10) 23* Any weight
Maternal weight change with intervention:
0.78 1.03 (0.74 to 1.42) 2‡ 0.70 0.79 (0.50 to 1.25) 5‡ 0.002 −170 (−300 to
−40)
7 Significantly
reduced
0.95 (0.64 to 1.42) 8‡ 0.88 (0.66 to 1.17) 12‡ −10 (−50 to −30) 24 No significant
change
Risk of bias (allocation concealment):
0.35 0.89 (0.63 to 1.25) 7 0.66 0.82 (0.63 to 1.08) 15 0.33 −60 (−120 to 0) 26 High risk
1.13 (0.79 to 1.62) 4 0.96 (0.51 to 1.80) 3 0 (−90 to 80) 5 Low risk
*Polley et al
66 data presented separately for normal weight women and overweight women.
†Phelan 2011 et al
65 data presented separately for normal weight women and overweight women.
‡Ferrara 2011 et al
58did not provide data for gestational weight gain.
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RESEARCHFigures
Fig 1 Identification of studies in systematic review of effects of dietary and lifestyle interventions in pregnancy on maternal
and fetal outcomes
Fig 2 Quality of randomised controlled trials included in systematic review of dietary and lifestyle interventions in pregnancy
on maternal and fetal outcomes
Fig 3 Mean difference in gestational weight gain (kg) with dietary and lifestyle interventions in pregnancy
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RESEARCHFig 4 Mean difference in birth weight (g) with dietary and lifestyle interventions in pregnancy
Fig 5 Relative risk of effect on size for gestational age with dietary and lifestyle interventions in pregnancy
Fig 6 Relative risk of effects of weight management interventions in pregnancy on maternal outcomes
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RESEARCHFig 7 Relative risk of effects of weight management interventions in pregnancy on fetal and neonatal outcomes
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